{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:51:46Z","timestamp":1747381906737,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ajpc.2024.100669","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T02:27:21Z","timestamp":1713234441000},"page":"100669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["US population qualifying for aspirin use for primary prevention of cardiovascular disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Athena L.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Marie","family":"Navar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colby","family":"Ayers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Rohatgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parag","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7255-6874","authenticated-orcid":false,"given":"Amit","family":"Khera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ajpc.2024.100669_bib0001","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.2022.3337","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the us preventive services task force","volume":"327","author":"Guirguis-Blake","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ajpc.2024.100669_bib0002","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ajpc.2024.100669_bib0003","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"issue":"10152","key":"10.1016\/j.ajpc.2024.100669_bib0004","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (arrive): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ajpc.2024.100669_bib0005","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2024.100669_bib0006","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey. https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm."},{"issue":"25, suppl 2","key":"10.1016\/j.ajpc.2024.100669_bib0007","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25, suppl 2):S74-S75]","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"year":"2022","series-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: an updated decision analysis for the U.S. Preventive Services Task Force","author":"Dehmer","key":"10.1016\/j.ajpc.2024.100669_bib0008"},{"issue":"24","key":"10.1016\/j.ajpc.2024.100669_bib0009","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2018.8194","article-title":"Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy","volume":"319","author":"Selak","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2024.100669_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pcad.2022.08.007","article-title":"Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA\/ACC\/multi-society guideline recommendations: from National Health and Nutrition Examination Survey","volume":"75","author":"Gupta","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"issue":"19","key":"10.1016\/j.ajpc.2024.100669_bib0011","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.119.045010","article-title":"Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA Study (Multi-Ethnic Study of Atherosclerosis)","volume":"141","author":"Cainzos-Achirica","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajpc.2024.100669_bib0012","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10935-019-00564-1","article-title":"Risk of atherosclerotic cardiovascular disease among US adults: use of 1999\u20132014 NHANES Data","volume":"40","author":"Moss","year":"2019","journal-title":"J Prim Prev"},{"issue":"13","key":"10.1016\/j.ajpc.2024.100669_bib0013","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajpc.2024.100669_bib0014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.amjcard.2010.08.041","article-title":"Comparison of the racial\/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis","volume":"107","author":"Sanchez","year":"2011","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.ajpc.2024.100669_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013404","article-title":"Low-dose aspirin for primary prevention of cardiovascular disease: use patterns and impact across race and ethnicity in the Southern Community Cohort Study","volume":"8","author":"Fernandez-Jimenez","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ajpc.2024.100669_bib0016","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamacardio.2020.4939","article-title":"Value of coronary artery calcium scanning in association with the net benefit of aspirin in primary prevention of atherosclerotic cardiovascular disease","volume":"6","author":"Ajufo","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"14","key":"10.1016\/j.ajpc.2024.100669_bib0017","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2022.07.027","article-title":"Aspirin for primary prevention of cardiovascular events in relation to lipoprotein(a) genotypes","volume":"80","author":"Lacaze","year":"2022","journal-title":"J Am Coll Cardiol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667724000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667724000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T09:17:57Z","timestamp":1719047877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667724000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":17,"alternative-id":["S2666667724000370"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2024.100669","relation":{},"ISSN":["2666-6677"],"issn-type":[{"type":"print","value":"2666-6677"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"US population qualifying for aspirin use for primary prevention of cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2024.100669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100669"}}